{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T18:11:38Z","timestamp":1785435098856,"version":"3.56.0"},"reference-count":12,"publisher":"Elsevier BV","issue":"39","license":[{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1016\/j.vaccine.2009.06.106","type":"journal-article","created":{"date-parts":[[2009,7,27]],"date-time":"2009-07-27T08:08:50Z","timestamp":1248682130000},"page":"5293-5294","source":"Crossref","is-referenced-by-count":9,"title":["Inactivated Polio Vaccine (IPV): A strong candidate vaccine for achieving global polio eradication program"],"prefix":"10.1016","volume":"27","author":[{"given":"Aamir","family":"Shahzad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gottfried","family":"K\u00f6hler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2009.06.106_bib1","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1146\/annurev.micro.58.030603.123625","article-title":"Vaccine derived polioviruses and the endgame strategy for global polio eradication","volume":"59","author":"Kew","year":"2005","journal-title":"Annu. Rev. Microbiol."},{"key":"10.1016\/j.vaccine.2009.06.106_bib2","series-title":"Epidemiology and prevention of vaccine-preventable diseases","author":"Atkinson","year":"2007"},{"key":"10.1016\/j.vaccine.2009.06.106_bib3","series-title":"The immunological basis for immunization series","author":"Robertson","year":"2008"},{"key":"10.1016\/j.vaccine.2009.06.106_bib4","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/rmv.1980030305","article-title":"Immunization against polioviruses in developing countries","volume":"3","author":"John","year":"1993","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.vaccine.2009.06.106_bib5","first-page":"27","article-title":"The elimination of polio in the Scandinavian countries","volume":"21","author":"Bottiger","year":"1993","journal-title":"Public Health Rev."},{"key":"10.1016\/j.vaccine.2009.06.106_bib6","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1093\/infdis\/162.6.1291","article-title":"Comparative evaluation of immunization with live attenuated and enhanced potency inactivated trivalent poliovirus vaccines in childhood: systemic and local immune responses","volume":"162","author":"Faden","year":"1990","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.vaccine.2009.06.106_bib7","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1586\/14760584.8.1.5","article-title":"Role of injectable and oral polio vaccines in polio eradication","volume":"8","author":"John","year":"2009","journal-title":"Expert Rev. Vac."},{"key":"10.1016\/j.vaccine.2009.06.106_bib8","doi-asserted-by":"crossref","unstructured":"Poliomyelitis prevention: recommendations for use of inactivated poliovirus vaccine and live oral poliovirus vaccine. American Academy of Pediatrics Committee on Infectious Diseases. Pediatrics 1997, vol. 99 pp. 300\u2013305.","DOI":"10.1542\/peds.99.2.300"},{"issue":"16","key":"10.1016\/j.vaccine.2009.06.106_bib9","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1016\/j.vaccine.2008.02.008","article-title":"Economics of polio vaccination in the post-eradication era: should OPV-using countries adopt IPV?","volume":"26","author":"Mahmud Khan","year":"2008","journal-title":"Vaccine"},{"issue":"15-16","key":"10.1016\/j.vaccine.2009.06.106_bib10","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1016\/j.vaccine.2004.01.008","article-title":"Technologies that make administration of vaccines safer","volume":"22","author":"Clements","year":"2004","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2009.06.106_bib11","doi-asserted-by":"crossref","first-page":"599","DOI":"10.2105\/AJPH.48.5.599","article-title":"Antibody response to poliomyelitis vaccine administered by jet injection","volume":"48","author":"Lipson","year":"1958","journal-title":"Am. J. Public Health Nations Health"},{"key":"10.1016\/j.vaccine.2009.06.106_bib12","unstructured":"WHO. The polio pipeline newsletter. A quarterly update of ongoing research in the global polio eradication initiative. WHO Summer 2008;(1)."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09010287?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09010287?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,21]],"date-time":"2019-05-21T18:11:15Z","timestamp":1558462275000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X09010287"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8]]},"references-count":12,"journal-issue":{"issue":"39","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["S0264410X09010287"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.06.106","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,8]]}}}